Not applicableStudy completedNCT00034086What this trial is testingStudy of Anti-HIV Therapy IntensificationWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 22
Large-scale testing (Phase 3)WithdrawnNCT00476983What this trial is testingPharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mgWho this might be right forSaquinavir/Ritonavir BID or Lopinavir/Ritonavir BID The HIV Netherlands Australia Thailand Research Collaboration
Post-approval studies (Phase 4)Ended earlyNCT00765154What this trial is testingNNRTI/PI Toxicity Switch to Darunavir StudyWho this might be right forHIV St Stephens Aids Trust 12
Large-scale testing (Phase 3)Study completedNCT00043966What this trial is testingStudy of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve SubjectsWho this might be right forHIV Infections Abbott 200
Post-approval studies (Phase 4)Study completedNCT00148759What this trial is testingKaletra Sex/Gender Pharmacokinetics (PK) StudyWho this might be right forHIV Infections Emory University 23
Post-approval studies (Phase 4)UnknownNCT04350684What this trial is testingUmifenovir in Hospitalized COVID-19 PatientsWho this might be right forCOVID-19 Shahid Beheshti University of Medical Sciences 40
Early research (Phase 1)Study completedNCT00697892What this trial is testingPharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug CombinationsWho this might be right forHIV InfectionsMalaria Fran Aweeka 38
Post-approval studies (Phase 4)Study completedNCT04252885What this trial is testingThe Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus InfectionWho this might be right forCoronavirus Infections Guangzhou 8th People's Hospital 86
Testing effectiveness (Phase 2)Study completedNCT00075231What this trial is testingA Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected SubjectsWho this might be right forHIV Infections Abbott 150
Post-approval studies (Phase 4)Ended earlyNCT01031849What this trial is testingAnalysis of Changes in Adipose Tissue of Patients With Lipoatrophy HIV Infection Treated With Nucleoside Thymidine, After Switching to Monotherapy With Lopinavir / RitonavirWho this might be right forHIV Infections Ines Perez 7
Large-scale testing (Phase 3)Ended earlyNCT00144833What this trial is testingOpen Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV SubjectsWho this might be right forHIV-1 GlaxoSmithKline 150
Post-approval studies (Phase 4)Study completedNCT00810108What this trial is testingLopinavir/Ritonavir (Kaletra) PK in ChildrenWho this might be right forHIV/AIDS TreatmentHIV Infections Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 12
Testing effectiveness (Phase 2)Study completedNCT02415985What this trial is testingPharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice WeeklyWho this might be right forHIVTuberculosis The HIV Netherlands Australia Thailand Research Collaboration 40
Post-approval studies (Phase 4)Ended earlyNCT00981318What this trial is testingPilot Assessment of Lopinavir/Ritonavir and MaravirocWho this might be right forHIV InfectionsAcquired Immunodeficiency Syndrome Rodwick, Barry M., M.D. 3
Large-scale testing (Phase 3)Study completedNCT00234910What this trial is testingEfficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected PatientsWho this might be right forHIV Infection Abbott 152
Large-scale testing (Phase 3)UnknownNCT00025727What this trial is testingComparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological FailureWho this might be right forHIV Infections GlaxoSmithKline 330
Testing effectiveness (Phase 2)Study completedNCT00004578What this trial is testingABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected SubjectsWho this might be right forHIV Infections Abbott 100
Not applicableStudy completedNCT00357552What this trial is testingSafety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV TherapyWho this might be right forHIV Infections Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 123
Post-approval studies (Phase 4)Ended earlyNCT00234962What this trial is testingStudy of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral TherapyWho this might be right forHIV Infection Abbott 200
Testing effectiveness (Phase 2)UnknownNCT01663168What this trial is testingEARNEST Rifabutin Pharmacokinetics (PK) SubstudyWho this might be right forHIVTuberculosis Justine Boles 140